18β-Glycyrrhetinic Acid Improves Cardiac Diastolic Function by Attenuating Intracellular Calcium Overload

Abstract

Ranolazine, a late sodium current inhibitor, has been demonstrated to be effective on heart failure. 18β-glycyrrhetinic acid (18β-GA) has the similar inhibitory effect on late sodium currents. However, its effect on diastolic function is still unknown. This study aimed to determine whether 18β-GA can improve the diastolic function and to explore the underlying mechanisms. Eighty male Sprague Dawley (SD) rats of Langendorff model were randomly divided into the following groups: group A, normal cardiac perfusion group; group B, ischemia-reperfusion group; group C, ischemia-reperfusion with anemoniasulcata toxin II (ATX-II); group D, ranolazine group; and group E, 18β-GA group with four different concentrations. Furthermore, a pressure-overloaded rat model induced by trans-aortic constriction (TAC) was established. Echocardiography and hemodynamics were used to evaluate diastolic function at 14th day after TAC. Changes of free intracellular calcium (Ca²⁺) concentration was indirectly detected by laser scanning confocal microscope to confirm the inhibition of late sodium currents. With the intervention of ATX-II on ischemia reperfusion injury group, 5 µmol/L ranolazine, and 5, 10, 20, 40 µmol/L 18β-GA could improve ATX-II-induced cardiac diastolic dysfunction. 630 mg/kg glycyrrhizin tablets could improve cardiac diastolic function in the pressure-overloaded rats. 18β-GA and ranolazine had similar effects on reducing the free calcium in cardiomyocytes. The study demonstrates that 18β-GA and glycyrrhizin could improve diastolic dysfunction induced by ischemia-reperfusion injury in Langendorff-perfused rat hearts and pressure-overloaded rats. The mechanism may be attributed to the inhibition of enhanced late sodium currents.

Keywords

glycyrrhetinic acid / diastolic function / calcium overload

References

[1] HasenfussG, SchillingerW, LehnartSE, et al.. Relationship between Na⁺-Ca²⁺-exchanger protein levels and diastolic function of failing human myocardium. Circulation, 1999, 99: 641-648

[2] BelardinelliaL, AntzelevitchC, FrasercH. Inhibition of late (sustained/persistent) sodium current: a potential drug target to reduce intracellular sodium-dependent calcium overload and its detrimental effects on cardiomyocyte function. Eur Heart J Suppl, 2004, 6(supplI): 13-17

[3] NobleD, NoblePJ. Late sodium current in the pathophysiology of cardiovascular disease: consequences of sodium-calcium overload. Heart, 2006, 92(Suppl 4): iv1-iv5

[4] HaleSL, ShryockJC, BelardinelliL, et al.. Late sodium current inhibition as a new cardioprotective approach. J Mol Cell Cardiol, 2008, 44(6): 954-967

[5] UndrovinasNA, MaltsevVA, BelardinelliL, et al.. Late sodium current contributes to diastolic cell Ca²⁺ accumulation in chronic heart failure. J Physiol Sci, 2010, 60(4): 245-257

[6] ContiCR. Ion channel therapy of ischemic heart disease: from calcium channel blockers to late sodium current inhibition. Clin Cardiol, 2011, 34(2): 66-67

[7] PourrierM, WilliamsS, McAfeeD, et al.. Cross Talk proposal: The late sodium current is an important player in the development of diastolic heart failure (heart failure with a preserved ejection fraction). J Physiol, 2014, 592(3): 411-414

[8] El-SaberBG, MagdyBA, El-MleehA, et al.. Traditional Uses, Bioactive Chemical Constituents, and Pharmacological and Toxicological Activities of Glycyrrhiza glabra L. (Fabaceae). Biomolecules, 2020, 10(3): 352

[9] PastorinoG, CornaraL, SoaresS, et al.. Liquorice (Glycyrrhiza glabra): A phytochemical and pharmacological review. Phytother Res, 2018, 32(12): 2323-2339

[10] MiuraT, OhnumaY, KunoA, et al.. Protective role of gap junctions in preconditioning against myocardial infarction. Am J Physiol Heart Circ Physiol, 2004, 286(1): 214-221

[11] SuDC, ChangZW, FanSY. Role of gap junction in ischemic preconditioning. Zhonghua Xin Xue Guan Bing Za Zhi (Chinese), 2006, 34(8): 690-694

[12] SossallaS, WagnerS, RasenackEC, et al.. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts—role of late sodium current and intracellular ion accumulation. J Mol Cell Cardiol, 2008, 45(1): 32-43

[13] WilliamsS, PourrierM, McAfeeD, et al.. Ranolazine improves diastolic function in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol, 2014, 306(6): H867-881

[14] HwangH, ArcidiJMJr., HaleSL, et al.. Ranolazine as a cardioplegia additive improves recovery of diastolic function in isolated rat hearts. Circulation, 2009, 120(11Suppl): S16-21

[15] CoppiniR, FerrantiniC, YaoL, et al.. Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy. Circulation, 2013, 127(5): 575-584

[16] DuYM, ZhangS, WuH, et al.. Glycyrrhetinic acid blocks cardiac sodium channels expressed in Xenopus oocytes. J Ethnopharmacol, 2009, 125(2): 318-323

[17] BellRM, MocanuMM, YellonDM. Retrograde heart perfusion: the Langendorff technique of isolated heart perfusion. J Mol Cell Cardiol, 2011, 50(6): 940-950

[18] JayasooriyaRG, DilsharaMG, ParkSR, et al.. 18β-Glycyrrhetinic acid suppresses TNF-α induced matrix metalloproteinase-9 and vascular endothelial growth factor by suppressing the Akt-dependent NF-κB pathway. Toxicol In Vitro, 2014, 28(5): 751-758

[19] XiaoY, XuJ, MaoC, et al.. 18β-glycyrrhetinic acid ameliorates acute Propionibacterium acnes-induced liver injury through inhibition of macrophage inflammatory protein-1alpha. J Biol Chem, 2010, 285(2): 1128-1137

[20] HuangM, XieX, GongP, et al.. A 18β-glycyrrhetinic acid conjugate with Vorinostat degrades HDAC3 and HDAC6 with improved antitumor effects. Eur J Med Chem, 2020, 188: 111

[21] ZhangP, ChangZ, YangJ, et al.. Vasorelaxation effect of 18β-glycyrrhetinic acid on the thoracic aorta of rats: proposed mechanism. Pharmazie, 2019, 74(12): 751-754

[22] TamirS, EM, SomjenD, et al.. Estrogen-like activity of glabrene and other constituents isolated from licorice root. J Steroid Biochem Mol Biol, 2001, 78(3): 291-298

[23] SomjenD, KnollE, VayaJ, et al.. Estrogen-like activity of licorice root constituents: glabridin and glabrene, in vascular tissues in vitro and in vivo. J Steroid Biochem Mol Biol, 2004, 91(3): 147-155

[24] ChungTH, WangSM, ChangYC, et al.. 18β-glycyrrhetinic acid promotes src interaction with connexin43 in rat cardiomyocytes. J Cell Biochem, 2007, 100(3): 653-664

[25] ZazaA, BelardinelliL, ShryockJC. Pathophysiology and pharmacology of the cardiac “late sodium current”. Pharmacol Ther, 2008, 119(3): 326-339

[26] ParisellaML, AngeloneT, GattusoA, et al.. Glycyrrhizin and glycyrrhetinic acid directly modulate rat cardiac performance. J NutrBiochem, 2012, 23(1): 69-75

[27] ZhangY, YuL, JinW, et al.. Reducing toxicity and increasing efficiency: aconitine with liquiritin and glycyrrherinic acid regulate calcium regulatory proteins in rat myocardial cell. Afr J Tradit Complement Altern Med, 2017, 14(4): 69-79

[28] WangL, HeY, ZhangY, et al.. Effects of Active Components of Fuzi and Gancao Compatibility on Bax, Bcl-2, and Caspase-3 in Chronic Heart Failure Rats. Evid Based Complement Alternat Med, 2016, 2016: 7686045

[29] OjhaSK, SharmaC, GolechhaMJ, et al.. Licorice treatment prevents oxidative stress, restores cardiac function, and salvages myocardium in rat model of myocardial injury. Toxicol Ind Health, 2015, 31(2): 140-152

[30] ZhangM, WangC, CaiHL, et al.. Licorice Extracts Attenuate Nephrotoxicity Induced by Brucine through Suppression of Mitochondria Apoptotic Pathway and STAT3 Activation. Curr Med Sci, 2019, 39(6): 890-898

[31] JeongEM, DudleySJr.. Diastolic Dysfunction: Potential New Diagnostics and Therapies. Circ J, 2015, 79(3): 470-477

[32] OjhaS, GolechhaM, KumariS, et al.. Glycyrrhiza glabra protects from myocardial ischemia-reperfusion injury by improving hemodynamic, biochemical, histopathological and ventricular function. Exp Toxicol Pathol, 2013, 65(1–2): 219-227

[33] ZhangXQ, YamadaS, BarryWH. Ranolazine inhibits an oxidative stress-induced increase in myocyte sodium and calcium loading during simulated-demand ischemia. J Cardiovasc Pharmacol, 2008, 51: 443-449

[34] DuYM, XiaCK. 18β-Glycyrrhetinic acid preferentially blocks late Na current generated by ΔKPQ Nav1.5 channels. Acta Pharmacologica Sinica, 2012, 33: 752-760

[35] ÅsmundTR, MichaelF, WilliamEL. Targeting Cardiomyocyte Ca²⁺ Homeostasis in Heart Failure. Curr Pharm Des, 2015, 21(4): 431-448